|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07D 277/28 | (2006.01) |
| C07D 417/14 | (2006.01) | ||
| A61K 31/427 | (2006.01) | ||
| A61P 31/12 | (2006.01) |
| (11) | Number of the document | 2487162 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12167590.4 |
| Date of filing the European patent application | 2008-02-22 | |
| (97) | Date of publication of the European application | 2012-08-15 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-17 |
| (46) | Date of publication of the claims translation | 2016-11-10 |
| (30) | Number | Date | Country code |
| 903228 P | 2007-02-23 | US | |
| 958716 P | 2007-07-06 | US |
| (72) |
Desai, Manoj, C., US
Hong, Allen, Y., US
Hui, Hon, C., US
Liu, Hongtao, US
Vivian, Radall, W., US
Xu, Lianhong, US
|
| (73) |
GILEAD SCIENCES, INC.,
333 Lakeside Drive, Foster City, California 94404,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Terapinių agentų farmakokinetinių savybių moduliatoriai |
| Modulators of pharmacokinetic properties of therapeutics |
| Payment date | Validity (years) | Amount | |
| 2022-01-19 | 15 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2022-07-05 |